Biological activities for 'Ficus carica' latex for potential therapeutics in Human Papillomavirus (HPV) related cervical cancers by Ghanbari, Arshia et al.
1Scientific RepoRts |          (2019) 9:1013  | https://doi.org/10.1038/s41598-018-37665-6
www.nature.com/scientificreports
Biological activities of Ficus carica 
latex for potential therapeutics 
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Infection caused by high-risk human papillomaviruses (HpVs) are implicated in the aetiology of cervical 
cancer. Although current methods of treatment for cervical cancer can ablate lesions, preventing 
metastatic disseminations and excessive tissue injuries still remains a major concern. Hence, 
development of a safer and more efficient treatment modality is of vital importance. Natural products 
from plants are one of the principal sources of precursors to lead compounds with direct pharmaceutical 
application across all disease classes. one of these plants is Ficus carica, whose fruit latex, when applied 
on HpV-induced skin warts, has shown potential as a possible cure for this virus related lesions. this 
study explores the in vitro biological activities of fig latex and elucidates its possible mechanisms of 
action on cervical cancer cell lines CaSki and HeLa positive for HPV type 16 and 18, respectively. Our 
data shows that fig latex inhibits properties that are associated with HPV-positive cervical cancer 
transformed cells such as rapid growth and invasion and substantially downregulated the expression of 
p16 and HPV onco-proteins E6, E7. These findings suggest Ficus carica latex has the potential to be used 
in the development of therapeutic modalities for the possible treatment, cure and prevention of HpV 
related cervical cancer.
Cancer is a major public health concern and is one of the leading causes of death worldwide1. Cervical cancer 
is one of the most common types of cancer, affecting women on a global scale2. Infection caused by high-risk 
human papillomaviruses (HPVs), especially type 16 and 18 are implicated in the aetiology of most cervical can-
cers3. Coupled with their involvement in cancer, these viruses can cause life-long debilitating diseases that may 
be accompanied by a significant negative impact on quality of life. High-risk HPV infections interfere with the 
molecular pathways that are responsible for regulating epithelial differentiation as well as cell proliferation4,5.
HPV onco-proteins E6 and E7 contribute towards cellular changes in HPV infected cells. These facilitate the 
persistence of infection that might allow the progression of the lesions towards cancer6. E6 interacts physically 
with tumour suppressor protein p53 and prevents its function; this activity will ultimately impede apoptosis. On 
the other hand, E7 binds to retinoblastoma (Rb) protein and prevents the interaction of Rb with its natural target, 
namely transcription factor E2F. Consequently the checkpoint that controls G1/S transition becomes distorted, 
causing uncontrolled proliferative lesions7,8.
Once proliferative lesions persist they can progress to high-grade ones and become an invasive form of cervi-
cal cancer9,10. It has been demonstrated that the presence of even minimal amounts of HPV DNA are associated 
with an increased risk in the development of cervical cancer11. Given the importance of cervical cancer, to date, 
there has been no satisfactory medical treatment for human papillomavirus related cervical cancer as most of the 
developed treatments (e.g., surgical excision, chemotherapy, and cryotherapy) are eventually accompanied by 
excessive tissue injury12. Therefore, there is a continuing demand for development of new strategies for treatment, 
which avoids tissue injury.
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Herbal medicinal and biological studies have revealed that public interest in utilising traditional remedies has 
greatly increased13–15. Among the such medically relevant plants, the fig latex (Ficus carica), when applied to low 
risk human papillomavirus (HPV) related skin warts and bovine papillomavirus (BPV) related warts, has shown 
potential as a possible cure for the virus without inevitable tissue injury and remedial complications16–18. Fig latex 
also reportedly offers various therapeutic effects such as anti-Herpes Simplex Virus (HSV)-119, anti-bacterial 
activity20, anthelmintic21. As a consequence we investigated the biological activity of the Ficus carica latex on high 
risk HPV related cervical cancer. Herein, we show that Ficus carica latex effectively inhibits growth of HPV pos-
itive cervical cancer cells (CaSki and HeLa), without a cytotoxic effect on HPV and cancer-free human immor-
talised keratinocyte (HaCaT) cell line. The latex presents anti-cancer effects by various mechanisms, including 
induction of apoptosis and inhibition of cell transformation; colony formation, cell proliferation, migration and 
invasion. In addition to its potent anti-cancer effects, the results obtained indicate that Fig latex has profound 
influence on the deregulation of HPV oncoproteins (E6 and E7) and HPV diagnostic marker protein (p16) and 
initiates the reactivation of Rb and p53 tumor suppressor proteins. These findings provide insight into new ther-
apeutic avenues against HPV-associated cervical cancers.
Material and Methods
Cell culture and cell lines. Cervical cancer cell lines positive for HPV type 16 (CaSki) and HPV type 18 
(HeLa) and HPV free Human immortalised Keratinocytes (HaCaT) were used for this study. CaSki cells were 
maintained in Roswell Park Memorial Institute medium (RPMI-1640) (Sigma, UK), HeLa cells in Eagle’s 
Minimum Essential Medium (EMEM) (ATCC, UK) and HaCaT cells in Dulbecco’s Modified Eagle’s Medium 
(DMEM) (Life science, USA). All medias were supplemented with 10% Fatal Calf serum (FCS) (Sigma) and pen-
icillin (100 U/ml; Sigma) and streptomycin (100 µg/ml; Sigma). Cell culture work was performed following strict 
aseptic techniques inside a laminar flow hood. All cells were incubated in a 5% CO2 incubator at 37 °C.
Collection and purification of fig latex. Fig fruit latex was collected drop-by-drop without squeezing 
over summer months from unripe fruits of fig trees in the suburb of Tehran (Solughan-Iran) (Fig. 1) and 1 ml of 
the latex was put into in eppendorf tubes. Tubes were immediately stored at −20 °C until analysis. The latex was 
filtered using Whatman No. 1 (Fisher Scientific, UK) and centrifuged at 13000 rpm/4 °C to separate the polymeric 
gum from the aqueous filtrate part. Further purification of the aqueous part was subsequently attained by filtra-
tion using a 5 µm disposable filter membrane (Sigma, UK).
Separation of fig latex supernatant extracts. Approx 40 mg of each crude Fig Latex sample was dis-
solved in 2 ml of a 90/10 v/v mixture of distilled water and D2O. The internal standard TSP (trimethylsilylpro-
pionate sodium salt) was added to a concentration of 1.52 mM and each sample was shaken for a minimum of 
8 min and solution confirmed, before transfer to an NMR tube. Each sample was allowed to equilibrate within the 
NMR spectrometer for 5 min. All NMR experiments were carried out at 25 °C. All crude spectra were acquired on 
Topspin 3.0 (BrukerBioSpin GmbH, Rheinstetten, Germany) and 64 K complex data points were acquired over a 
sweep width of 20.57ppm with a D1 relaxation delay of 4 s with water suppression afforded by the noesygppr1d 
sequence.
Extraction of fig latex supernatant extracts. Fig latex supernatant (1 ml) was extracted into 3 × 5 ml 
Petroleum Ether 60/40. The residue was then extracted using 3 × 5 ml CHCl3. The final residue was taken up 
CH3CN. After the extractions, the individual organic extracts were combined and the solvents removed under 
reduced pressure. Each of the resulting powders was then assessed for cytotoxic activity.
NMR Analysis. A Bruker Avance III 600 MHz NMR spectrometer with 5 mm TXI Probe and temperature 
control unit was used for all 1 H and 2D NMR experiments; 5-mm Bruker Single Use NMR tubes (Product Code 
Figure 1. (a) Extracted ion chromatogram in positiv ion mode of m/z 409.3740 and (b) tandem mass spectrum 
showing the fragmentation of three isomers of m/z 409.3740 in Ficus oil extract.
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Z117777) were used. All chemicals were sourced from Sigma-Aldrich and were used without further purification 
unless otherwise stated. The petroleum ether fraction of the fig latex supernatant was taken up in CDCl3 and 1H, 
13C, 1H-1H COSY, 1H-1H TOCSY and 1H-13C HSQC experiments undertaken to aid in assigning the main types 
of components.
Ms Analysis. Ethanol gradient grade was purchased from Merck (Darmstadt, Germany), isopropanol 
(Rotisolv® HPLC grade), acetonitrile (Rotisolv® HPLC ultra gradient grade), chloroform (Rotisolv® HPLC 
grade) and Tetra-dodecylammonium bromide was purchased from Carl Roth (Karlsruhe, Germany), ammonium 
formate LC-MS Ultra and formic acid (puriss., ≥98% (T) for mass spectrometry), and acetic acid were purchased 
from Sigma-Aldrich Chemie (Steinheim, Germany). Ethanol was subjected to distillation prior use.
sample preparation. For HPLC analysis, a concentration of 0.045 mg/mL in chloroform/ethanol (50/50) of 
ficus oil extract was prepared.
HpLC chromatographic conditions. Lipid molecular species were separated using an HPLC equipment 
(Agilent 1100 series, Waldbronn, Germany). The column used in this study was a Pursuit XRs C18 (250 mm × 3 mm 
i.d., 5 μm particles). The temperature of the column oven was set to 35 °C. 3 µL of sample were injected. Solvent 
A consisted of acetonitrile with 0.01% formic acid and solvent B consisted of ethanol with 10 mM/L ammonium 
formate and 0.01% formic acid. The mobile phase was pumped through the column at a flow rate of 0.6 mL/min. 
The gradient elution program consisted of holding solvent steady A (100) for 5 min; followed by a linear gradient to 
solvent A/B (70/30) for another 5; then by a linear gradient to solvent B (100) for 90 min, and ending with isocratic 
elution at solvent B (100) for 10 min. The column was equilibrated at 100 solvent A for 5 min before reuse.
High-resolution mass spectrometry conditions. High-resolution mass values were acquired using a 
time of flight MicrOTOF Focus mass spectrometer (Bruker Daltonics UHT Ultra, Bremen, Germany) fitted with 
an ESI source used as the detector with the following parameter settings: capillary voltage of 4.5 kV; nebulizing 
gas pressure of 2 Ba; drying gas flow rate of 10 L/min; drying gas temperature of 220 °C. ESI mass spectra were 
measured in the range of m/z 200–1200 in the positive ion mode. Internal calibration was achieved with 10 mL of 
0.1 M sodium formate solution injected through a six-port valve prior to each chromatographic run. Calibration 
was carried out using the enhanced quadratic mode.
tandem Mass spectrometry conditions. LC-tandem MS was carried out using an Ion-Trap detector in 
positive ion mode equipped with an ESI source (Bruker Daltonics UHT Ultra, Bremen, Germany). The full scan 
mass spectra were recorded in the range m/z 200–1200 operating in positive ion mode. Capillary temperature 
was set to 350 °C, drying gas flow rate of 10 L/min and nebulizer pressure of 10 psi. Tandem mass spectra were 
acquired in Auto MSn (smart fragmentation) using a ramping of the collision energy.
Cytotoxicity assay using Mtt. In order to investigate the effect of fig latex on cell growth HPV expressing 
cervical cancer cells (CasKi and HeLa), and control HaCaT cells (4 × 103) were seeded in 96 well plate. The follow-
ing day, cells were treated with various concentrations (0.125, 0.25, 0.5, and 1 µg/ml) of fig latex. After 24, 48 and 
72 hours, 20 µl of MTT (Sigma, UK) solution 5 mg/ml in phosphate buffer solution (Thermofisher, UK) was 
added in to each well and plates were cultivated at 37 °C in 5% CO2 for 3–4 hours. Afterward, the supernatant was 
removed, the remaining formazan crystals were dissolved in 100 µl of DMSO and the absorbance was measured 
at 540 nm with an Epoch plate reader (BioTek, UK) considering wells without cells as blank. Obtained values were 
analysed with Gen5 software (BioTek, UK). The percent of proliferation in each treated cell line was normalised 
based on their control wells. All experiments were performed at least in triplicate.
Colony forming assay. Cells were plated at approximately 600 cells/well in 2.5 ml media in 6-well corning 
plate and cultivated for 12 hrs to adhere. After that, cells were treated with concentrations of 0.125 µg/ml and 
0.25 µg/ml of fig latex for period of 14 days. The cells were then washed 3 times in PBS (Thermo Fisher, UK), 
fixed in formaldehyde 3.7% (Sigma, UK), and stained with crystal violet (Sigma, UK). Visible colonies (~35–50 
cells) were counted and presented as the ratio of the number of colonies in treated cells divided by the number of 
colonies in the control ones.
Ki67 proliferation. For this assay, cells (1 × 103) were seeded into 24-well plates containing coverslips. The 
following day, cells were treated with concentration of 0.125 µg/ml of fig latex for 48 hours. Afterward, cells were 
fixed in formaldehyde 3.7%, permeablisied in 0.1% triton-100 and blocked using BSA/PBS 3%. To detect Ki67 
antibody, cells were incubated with Anti-ki67 Rabbit mAb (1:200) followed by Gout Anti-Rabbit (1:250). Cells 
were then washed in PBS 0.1% Tween-20 for five times and incubated with DAPI. The coverslips were then 
mounted onto slides. The images were captured using LEICA TCS SP scanner microscope and were analyzed by 
Leica Confocal Software (Heidelberg, Germany).
Cell migration and invasion assays. Cell migration and invasion assays were performed using 24-well 
Transwell chamber with pore size 8 µm. 250 µl of cell suspension (50,000) without FCS was added into upper cham-
ber and lower chamber was filled with medium containing 10% FCS as a chemoattractant. For cell invasion assay 
250 µl of Extracellular Matrix (ThermoFisher) was added to lower chamber. 0.125 µg/ml of fig latex was added to 
upper chamber, cells were then cultivated at 37 °C for 24 hours in order to migrate and or invade from upper cham-
ber towards lower one. Following that, cell from upper chamber removed gently with cotton swap, washed in PBS, 
fixed with formaldehyde 3.7% and stained with crystal violet 0.2%. All experiments were repeated at least three 
times. The number of cells was counted in 5 fields randomly and was scored based on their untreated wells.
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Cell Cycle Analysis. Cell cycle distribution was assesses by flow cytometry. Cells were treated with 0.125 µg/
ml of fig latex or equivalent amount of PBS for 48 hrs. Approximately (1 × 106) cells were harvested from both 
control and treated flasks. Cells were then washed in PBS and fixed in 70% ice-cold ethanol for 1 hr. Then 500 µl 
of PI/RNase (Thermofisher, UK) was added to samples and were kept in the dark for 20 minutes at 37 °C. Stained 
cells were then excited at 488 nm using the FL-3 detector (620 nM) of a BD FACsCalibur flow cytometer 
(Becton-Dickinson). Acquired data was analysed using CellQuest software (Becton-Dickinson).
Western Blot. To investigate the effects of fig latex on HPV oncoproteins (E6 & E7), tumor suppressor pro-
teins (P53 & Rb) and HPV infection surrogate marker (P16), standard semi-dry western blotting technique was 
used. Cells were treated with concentration 0.125 µg/ml of fig latex for 48 hrs then proteins were extracted using 
RIPA buffer (Life Technologies, UK) and equal amounts of protein were electrophoresed. Membranes were 
blocked with 5% (w/v) non-fat dry milk in TBS-T (10 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 1% (v/v) 
Tween20) at room temperature for 2 hours to reduce non-specific binding and incubated with the mAb 
Anti-HPV16 E6 + HPV18 E6 antibody (1:500; Abcam), mAb Anti-HPV16 E7 (1:500; Abcam) + HPV18 E7 
(1:750; Abcam) antibody, Anti P53 antibody (1:500; Abcam), Anti Rb Antibody (1:1000; Abcam) Anti p16 anti-
body (1:750; Abcam) followed by Donkey anti-mouse (1:10000; Abcam) and actin antibody (1:10000). The mem-
brane was then visualised by OdysseyCLx Imaging System (Li-COR).
statistical Analysis. Statistical analyses were performed using Microsoft Excel 2011 version (14.3.8). The corre-
lations between cell viability and response to treatment were analysed using logarithmic regression of line. To calculate 
IC50 we obtained logarithmic regression of line (y = a ln (x) + b), using Excel. Since we were looking for inhibitory con-
centration for 50% of the cells, y value (axis) was equaled to 50. A and b values were given by excel therefore; calculation 
of x value was performed. X value represents concentration. Values were presented as mean standard error of the mean 
(S.E.M.). Statistical analyses were performed employing an unpaired, two-tailed student’s t-test. *p < 0.05 **p < 0.01, 
***p < 0.001 were considered statistically significant, very significant and extremely significant.
Results
Chemical Analysis of Ficus carica Latex. Fig latex is a milky fluid comprising aqueous medium and gum 
that makes the latex sticky and solidifies on exposure to air. Direct application of milky fluid on cells as well as 
preparation of serial dilution for molecular biology studies was limited due to the stickiness of latex. To overcome 
this restriction and determine the active biological compartment of fig latex for therapeutic approaches, chem-
ical components of lyophilized, aqueous part and polymeric gum of fig latex were compared using NMR and 
MS. Crude NMR analysis (see Supporting Information S1) revealed significant differences between the chemical 
constituents of the lyophilised latex and the aqueous part of the latex. Polymeric gum did not present significant 
chemical components. The components in the aqueous part of the latex are easier to discern than in as the crude 
latex (Lyophilised latex powder). The powder shows a mixture of saturated and unsaturated fatty acids/triglycer-
ides. The aqueous part of latex was as effective as the whole latex on cells from a biological activity perspective. 
Therefore, the aqueous part of the latex (supernatant) was used and exclaimed as “latex” throughout of this study.
In order to identify the nature of the chemical species responsible for this activity, the fig latex supernatant was 
extracted, first with petroleum ether, with subsequent extractions performed with increasing polarity solvents. 
After drying, these extracts were tested for anti-HPV activity. As a consequence of the pet ether extract of the fig 
latex supernatant showing the most potent anticancer activity, a more detailed analysis was carried out. Initial 
LC-MS data (Fig. 1) indicated that there were many isomers present with a mass of 409, molecular formula being 
C30H48. The tandem MS was consistent with a cyclic terpene.
2D NMR analysis supports the MS, and also suggests that there are steroidal compounds present in the pet 
ether extraction of the fig latex supernatant. Specifically, there is also evidence for the related phytosterol fatty acid 
glycosides - 6-O-acyl-β-D-glucosyl-β-sitosterols. There is a precedent for this as reported by Rubnov22. What is 
also worthy of note is the presence of phenolic components, which in the Pet. ether fraction are easy to visualise 
via NMR in the aromatic region (See Supporting Information S2). Whilst the analysis is preliminary and further, 
more demanding, purification steps will be required to narrow down the many components to that one active, 
there is evidence of either two ferulic/caffeic/chlorogenic acid components in the pet ether fraction. In isolation 
these would be unlikely to partition well into the Pet. ether fraction from the fig latex supernatant, owing to their 
hydrophilicity, but if covalently attached to a sterol or cyclic terpene, these derivatives, whilst anticipated, have not 
yet been reported in fig latex as being responsible for any of the observed biological activity.
LC-ESI-MS chromatogram in positive ion mode showed that the most abundant lipid compounds present in 
the oil have the masses between 300 and 450 m/z ratio and elute at very low Rt (Fig. 2(a,b)). The low Rt indicates 
that the most abundant compounds have a polar nature. Besides, the same chromatograms showed the occur-
rence of few triacylglycerol molecular species and the presence of a compound with m/z value of 409.3840 as a 
mixture of various isomers eluting at different Rt covering a wide range between 19.5 min and 100 min (Fig. 2(a)). 
High-resolution ESI-TOF mass spectrometer operating in the positive ion mode lead to the assignment of molec-
ular formulae of C30H49 with an error lower than 2 ppm. Tandem MS of the different isomers has shown similar 
fragmentation pattern resembling the tandem MS of a steroid compound. This supported the idea of oflanoster-
oltriene or oleandiene. This is supported by the NMR data. It was also observed that there were a few fatty acid 
glycosides of phytosterols e.g. stigmasterol, present in the supernatant (Fig. 2(c)).
The compounds eluting between 20 min and 30 min have shown the presence of molecular ion of m/z 
469.4047, which will correspond to the [M + H]+ of the isomers of triterpenoid phytosterol Lupeol acetate already 
described in literature23,24.
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Ficus carica Latex inhibits growth of cervical cancer cells. To assess the cytotoxic activity of fig latex 
on cells; HeLa, CaSki and HaCaT cells were treated with different concentrations (0.125, 0.25, 0.5, and 1 µg/ml) 
of fig latex for 24, 48 and 72 hours. Cell viability findings suggested that, the inhibitory effect of latex on cell 
growth occurs in a dose-dependent but not significantly time-dependent manner (Fig. 3). As shown in Fig. 3, a 
certain concentration (0.125 µg/ml) of fig latex for 48 could be used to suppress cervical cancer cell proliferation 
“without a toxicity” effect on the normal HaCaT cells. Thus, this concentration was used to further investigate the 
on anti-cancer activity of fig latex against cervical cancer cells.
Ficus carica latex suppresses clonogenic ability of cervical cancer cells. To evaluate anti clonogenic 
ability of fig latex in cervical cancer, CaSki and HeLa cells were treated with non-cytotoxic concentration 0.125 µ
g/ml of fig latex as well as 0.25 µg/ml for 14 days. This finding suggested that fig latex is able to seize the inhibitory 
effect of contact inhibition driven by cervical cancer (Fig. 4).
Ficus carica latex downregulates the expression of cellular proliferation marker, Ki67 pro-
tein. To investigate whether the fig latex influences cell growth in cervical cancer by targeting the Ki67 protein, 
control and cervical cancer cell lines were treated with a non-cytotoxic concentration (0.125 µg/ml) of fig latex for 
48 hours (Fig. 5). Data from this experiment showed that ki67 protein was expressed in untreated (control) and 
treated HaCaT cells as well as untreated cervical cancer cell line. As shown in Fig. 5, in cervical cancer cell lines 
(HeLa and CaSki) treated with fig latex, Ki67 protein was depleted almost exclusively in the nucleolus. This 
strongly suggests that fig latex may potentially target the expression of Ki67 in cervical cancer cells to prevent cell 
proliferation that could ultimately play a role in the inhibition of cancer progression.
Figure 2. (a) Two-dimensional (2D) map of lipid of Ficus oil, by reversed-phase high resolution HPLC/ESI-
MicroOTOF MS analysis. Colour rapresents the intensity of the signals (peaks) with red being the highest and 
blue the lowest and (b) HPLC-MS profile of Ficus oil in positive ionization mode. (c) MS determined structures 
of main chemical components of pet ether fraction of fig latex supernatant.
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Ficus carica latex suppresses cervical cancers migratory ability and alleviates invasiveness. To 
investigate whether fig latex could mediate migration and invasion abilities of cervical cancer cells, CaSki and 
HeLa cells were treated with 0.125 µg/ml of fig latex for 48 hrs and the numbers of migrated and invaded cells 
towards lower chambers of transwells were counted accordingly. Findings from this experiment (Fig. 6) show that 
Figure 3. 0.125 µg Fig Latex showed cytotoxicity effects on CaSki (B), HeLa (C) but not on HaCaT (A) cells. 
Cell viability was assessed using MTT assay after 24, 48 and 72 hours of treatment with fig latex. Results 
represent the means of at least 3 independent experiments and were normalised to control wells. Error bars 
indicate SEM; *p < 0.05, **p < 0.01, ***p < 0.001. (D) Determination of IC50 values following treatment with 
fig latex. Results represent the mean of at least 3.
Figure 4. Fig latex treatment inhibits colony formation in cervical cells. (A) Representative colony formation 
images of CaSki, HeLa and HaCaT cells with and without (control) treatment. (B) Graphs represent the 
inhibitory effects of treatments measured by colony counting. Error bars show SEM; Experiments, n = 3, 
average of three independent experiments; *p < 0.05, **p < 0.01, ***p < 0.001.
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fig latex may play a significant role on the suppression of migratory capabilities of cervical cancer cells and could 
alleviate their invasiveness.
Ficus carica latex induces cell cycle arrest in Sub G1 phase. To ascertain whether the growth- 
inhibitory effect of fig latex on CaSki and HeLa cells is related to the cell cycle arrest, cells were treated with 0.125 µg/ml 
of fig latex for 48 h and the distribution of cells in Sub G1, G1, S and G2/M phases was determined and compared before 
and after treatment with fig latex. Data from this experiment strongly suggest that fig latex induces cell death in Sub G1 
and accumulates G1 phase population in CaSki and HeLa cells. In contrast, HaCaT cells treated with fig latex showed 
approximately same ratio in all phases of the cell cycle (Fig. 7).
Ficus carica latex downregulates the expression of HpV onco-proteins and reactivates the 
expression of tumour suppressor proteins. To explore the effect of Ficus carica latex on HPV 
onco-proteins and tumor suppressor proteins, HeLa and CaSki cells were treated with 0.125 µg/ml of fig latex for 
Figure 5. Inhibitory effects of fig latex on Ki67 proliferation protein marker on cervical cancer cells. Following 
treatment with 0.125 μg/ml of latex for 48 hours, the level of ki67 protein expression in HaCaT cells did not change 
significantly. In contrast, level of ki67 expression was downregulated significantly in treated cervical cancer cell 
lines. This suggests the selective inhibitory effect of fig latex on expression of Ki67 in HPV positive cells.
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48 hrs. Expression of HPV oncoproteins (E7, E6), HPV diagnostic marker P16 and tumour suppressor proteins 
(P53, Rb) in treated and untreated cells were analysed using western blotting. Fig latex treatment downregulates 
the expression of E6, E7 and P16 and consequently upregulated the expression of tumour suppressor protein P53 
and Rb in cervical cancer cells (Fig. 8). These observations suggested that fig latex possess strong anti HPV 
activities.
Discussion
Although a few studies consider the distinctive medicinal features of fig latex, the mechanisms of action of the 
biologically active components of the Ficus carica species remains poorly understood. This study provides a 
deeper insight into the mechanisms of action and biological activities of Ficus carica latex on human cervical 
cancer cell lines expressing high risk HPVs type 16 and 18.
We report, for the first time, some of the chemical constituents of crude fig latex, aqueous supernatant and pol-
ymeric gum of fig latex using NMR/MS with the novel observation that the active anti-HPV component is likely 
to be lipophilic and possibly a chlorogenic/ferrulic/caffeic acid plant sterol derivative. Isolation/identification of 
the active from the Pet. ether fraction of the fig latex is now a priority, hampered by the limited amounts of fig 
latex that can be obtained from each plant. Our biological analysis confirms that the aqueous part of the latex is as 
effective as the crude latex and is suitable to carry out further functional studies. Using cell viability assay we have 
ascertained that the cytotoxic effect of latex on cell growth is dose-dependent and 0.125 μg/ml (IC50) of fig latex is 
the most appropriate concentration to investigate the activities of latex on cervical cancer cells. This obviates any 
toxic effect on the control human immortalised keratinocyte (HaCaT) cells, hence preventing any confounding 
data. These results corroborate the findings of previous studies on growth inhibitory effect of fig latex22,25,26.
We have extended our investigation on the functional activity of fig latex on cervical cancer cells to evaluate 
whether Ficus carica can inhibit specific properties of previously HPV related transformed cells.
Using a focus formation assay, we showed that only cervical cancer cells treated with the fig latex exit con-
tact inhibition, a characteristic feature of cancer cells. Contact inhibition regulates cell proliferation and arrest 
cancer cell growth as a consequence of mechanical cell to cell interaction27. In addition, we have investigated 
the influence of fig latex treatment on the cervical cancer cell lines and our data revealed that fig latex alleviates 
invasiveness ability of cervical cancer cells. This finding suggests that fig latex can prevent dissemination of can-
cer cells into new areas and may barricade formation of metastatic tumours. Coupled with this, treatment with 
Figure 6. Suppression of cell migration and invasiveness of cervical cancer cells. (A,C) Representative image of 
Transwell migration and invasion assays respectively. (B,D) Represents the inhibitory effect of Ficus carica latex 
on the number of migrated and invaded cervical cancer cells. Error bars show SEM; Experiments, n = 6, average 
of six independent images; *p < 0.05, **p < 0.01, ***p < 0.001.
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fig latex has allowed the cell cycle exit by inducing the cell cycle arrest in Sub G1 phase in cervical cancer cell 
lines. This finding demonstrates the ability of fig latex in preventing cell progression and proliferation. Cell cycle 
deregulation is known to be a significant element in cervical cancer carcinogenesis hence regulation of cancer 
cells division thorough induction of apoptosis is an efficient anti-cancer strategy28. Moreover, our data shows the 
misplacement of ki67 protein, a marker for cell proliferation29, in cervical cancer cells treated with the Ficus carica 
latex. This finding strongly suggests that fig latex may target the expression of Ki67 in cervical cancer cells and 
plays a substantial role in preventing cell proliferation that could ultimately inhibit cancer progression.
Figure 7. Effect of Ficus carica latex on cell cycle distribution of HaCaT, CaSki and HeLa cells. (A) 
Representative cell cycle analysis in treated and untreated cells. (B,C) Summarized cell cycle distribution 
data in untreated and treated cells respectively. Results were presented as mean (n = 3) ±SD of at least three 
independent experiments.
Figure 8. Effect of Ficus carica latex on the expression of HPV oncoproteins (E6 and E7), tumor suppressor 
proteins (P53 and Rb) and HPV diagnostic marker (P16). Equal amounts (10 µg) of protein lysate from each cell 
line listed were analyzed by immunoblotting with appropriate antibodies. Actin expression served as a loading 
control (42 kDa). Ficus carica latex down-regulated the expression of p16 and HPV oncproteins but upregulated 
the expression of tumour suppressor proteins. No significant differences were seen in the expression of actin. 
Un-cropped blots are available upon request.
www.nature.com/scientificreports/
1 0Scientific RepoRts |          (2019) 9:1013  | https://doi.org/10.1038/s41598-018-37665-6
Thus, our results demonstrate a number of parameters of cell transformation (lack of contact inhibition, cell 
cycle arrest, invasiveness, and cell proliferation) are conferred by the Fig latex.
As mentioned before, high risk HPVs, especially type 16 and 18, can infect cervical cells and cause lesions. 
These lesions can persist and progress to cancer by preventing the expression of tumour suppressor proteins 
(P53 and Rb)7. Expression of E6 and E7 promotes cell invasion and metastasis, impedes apoptosis, and induces 
uncontrolled cellular growth and immortalization6. E6 interacts with P53 that is substantially contributed to 
the regulation of cell cycle progression via apoptosis pathways, whereas E7 stimulates hyper proliferation of the 
infected cells through deactivation of Rb-dependent G1/S checkpoint activation8,30. In addition, Rb regulates p16 
via negative feedback system and therefore the Inhibition of Rb through E7 could increase the expression of p16. 
P16 acts as a negative regulator of proliferation in cells once the Rb has been inactivated29.
Nevertheless, to investigate if the effects of fig latex observed in this study were due to its impact on the expres-
sion of HPV oncoproteins, E6 and E7, we have further analysed the expression of these proteins in cervical cancer 
cells treated with the fig latex. Indeed, our findings from this study showed that fig latex considerably downreg-
ulates the expression level of HPV oncoproteins, E6 and E7 as well as p16 (marker for HPV infection) that was 
accompanied by an increase in expression level of P53 and Rb. These observations suggest that the in vitro effect 
of fig latex on the cervical cancer cell transformation might be due to remedial characteristics of the chemical 
constitute of fig latex on the expression of HPV oncoproteins.
In conclusion, our findings reveal that fig latex has a potential to play a role in preventing cervical cancer pro-
gression by inhibiting growth of cervical cancer cells through the upregulation of tumor suppressor proteins, p53 
and pRb, which is most likely a consequence of the reduced levels of E6 and E7, respectively.
The outputs of this study provide a strong incentive to advance research in delaying HPV related cancer progression.
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